Please assess the completion status of the following clinical trial:

Trial Title: Single Dose Versus Split Dose Polyethylene Glycol-based Colonic Lavage for Colonoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients between the age of 50 and 75 years referred to the Forzani \& MacPhail Colorectal Cancer Screening Centre in Calgary, Alberta, Canada for colonoscopy will be considered for inclusion.~Exclusion Criteria:~* patients with acute coronary syndrome,~* congestive heart failure,~* unstable angina,~* known or suspected renal failure,~* ascites,~* megacolon,~* known or suspected bowel obstruction, or~* other comorbidities that may prevent colonoscopy will be excluded. Patients will also be excluded if they previously had partial or subtotal colectomy or if the colonoscopy is warranted for the evaluation of diarrhea.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- PEG - 4 L (Type: EXPERIMENTAL): 4 Litres PEG bowel preparation given the day prior to colonoscopy with a clear fluid diet
- Split Dose PEG (Type: ACTIVE_COMPARATOR): 4 Litres of Colyte given as two split doses of 2L each either the day before colonoscopy 8 hours apart in the case of an AM colonoscopy or in the case of an afternoon colonoscopy given 5PM the day before and 6:00AM the day of the colonoscopy

Based on this trial design, predict the completion outcome and termination type (if applicable).